Friederike Pastore

1.2k total citations
12 papers, 303 citations indexed

About

Friederike Pastore is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Friederike Pastore has authored 12 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Friederike Pastore's work include Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Histone Deacetylase Inhibitors Research (3 papers). Friederike Pastore is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Histone Deacetylase Inhibitors Research (3 papers). Friederike Pastore collaborates with scholars based in Germany, United States and New Zealand. Friederike Pastore's co-authors include Karsten Spiekermann, Ross L. Levine, Wolfgang Hiddemann, G. Wittmann, Alessandro Pastore, Wolfgang E. Berdel, Bernhard J. Woermann, Jan Braess, Stephanie Schneider and Stefan K. Bohlander and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Friederike Pastore

11 papers receiving 301 citations

Peers

Friederike Pastore

HEMAT

GENET

PHEOH

ONCOL

Sofia Kade Germany

Barbara Rocca Italy

Patrick Löffeld Germany

Marilena Caresana Italy

Jörg Chromik Germany

B Przychodzen United States

Harmony Leroy France

Shiqiang Qu China

T. Haferlach Germany

Nanna Sulai United States

Sofia Kade Germany

Friederike Pastore

256 ×1.0

HEMAT

188 ×1.1

125 ×1.0

GENET

17 ×0.5

PHEOH

19 ×0.8

ONCOL

Citations per year, relative to Friederike Pastore Friederike Pastore (= 1×) peers Sofia Kade

Countries citing papers authored by Friederike Pastore

Since Specialization

Citations

This map shows the geographic impact of Friederike Pastore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friederike Pastore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friederike Pastore more than expected).

Fields of papers citing papers by Friederike Pastore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friederike Pastore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friederike Pastore. The network helps show where Friederike Pastore may publish in the future.

Co-authorship network of co-authors of Friederike Pastore

This figure shows the co-authorship network connecting the top 25 collaborators of Friederike Pastore. A scholar is included among the top collaborators of Friederike Pastore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friederike Pastore. Friederike Pastore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Fraccaroli, Alessia, et al.. (2023). Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcome. Annals of Hematology. 102(8). 2213–2223.

Pastore, Friederike, Alessandro Pastore, Maja Rothenberg‐Thurley, et al.. (2022). Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis. Cancer. 128(24). 4213–4222. 5 indexed citations

Bhagwat, Neha, Yang Zhang, Hong Lin, et al.. (2020). Abstract 2915: Preclinical characterization of PRT543, a potent and selective inhibitor of protein arginine methyltransferase 5 (PRMT5), with broad antitumor activity in in vitro and in vivo models. Cancer Research. 80(16_Supplement). 2915–2915. 5 indexed citations

Pastore, Friederike, et al.. (2020). JAK2S523L, a novel gain-of-function mutation in a critical autoregulatory residue in JAK2V617F− MPNs. Blood Advances. 4(18). 4554–4559. 2 indexed citations

Pronier, Elodie, Paolo Cifani, Amritha Varshini Hanasoge Somasundara, et al.. (2018). Targeting the CALR interactome in myeloproliferative neoplasms. JCI Insight. 3(22). 43 indexed citations

Konstandin, Nikola P., Friederike Pastore, Tobias Herold, et al.. (2018). Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA. Blood Advances. 2(20). 2724–2731. 38 indexed citations

Pastore, Friederike & Ross L. Levine. (2016). Epigenetic regulators and their impact on therapy in acute myeloid leukemia. Haematologica. 101(3). 269–278. 38 indexed citations

Janke, Hanna, Friederike Pastore, Tobias Herold, et al.. (2014). Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia. PLoS ONE. 9(3). e89560–e89560. 50 indexed citations

Pastore, Friederike, Philipp A. Greif, Stephanie Schneider, et al.. (2014). The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML. PLoS ONE. 9(10). e109759–e109759. 16 indexed citations

10.

Pastore, Friederike, Eva Hoster, Annika Dufour, et al.. (2014). Long-term follow-up of cytogenetically normal CEBPA-mutated AML. Journal of Hematology & Oncology. 7(1). 55–55. 34 indexed citations

11.

Pastore, Friederike, Alessandro Pastore, G. Wittmann, Wolfgang Hiddemann, & Karsten Spiekermann. (2014). The Role of Therapeutic Leukapheresis in Hyperleukocytotic AML. PLoS ONE. 9(4). e95062–e95062. 54 indexed citations

12.

Pastore, Friederike, Stephanie Schneider, Oliver Christ, Wolfgang Hiddemann, & Karsten Spiekermann. (2013). Impressive thrombocytosis evolving in a patient with a BCR-ABL positive CML in major molecular response during dasatinib treatment unmasks an additional JAK2V617F. Experimental Hematology and Oncology. 2(1). 24–24. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact